Background Laboratory testing is commonly performed in patients with COVID-19. Each of
the laboratory parameters has potential value for risk stratification and prediction of COVID …

As one year is approaching since the beginning of the Coronavirus disease 2019 (COVID‑
19) pandemic, it is important to acknowledge the detrimental effect that it is having on mental …

Abstract Background Coronavirus disease 2019 (COVID-19) has evolved into a worldwide
pandemic, and has been found to be closely associated with mental and neurological …

Aims We conducted a systematic review and meta-analysis to assess various antidiabetic
agents' association with mortality in patients with type 2 diabetes (T2DM) who have …

Objective The present study aimed to perform a systematic review and meta-analysis on the
prevalence of one-year hospital readmissions and post-discharge all-cause mortality in …

Currently, there is no widely acceptable and proven effective treatment for coronavirus
disease 2019 (COVID‐19). Colchicine has been shown to offer a benefit in reducing the …

Abstract Background Parkinson's Disease (PD) is among one of the common comorbidities
in older patients. People with PD may be more vulnerable to severe pneumonia, due to the …

Background: Persons living with human immunodeficiency virus (PLWH) constitute a
vulnerable population in view of their impaired immune status. At this time, the full interaction …

The severity of coronavirus disease 2019 (COVID-19) ranges from mild to death, with high
morbidity and mortality rates reported amongst a vulnerable subset of patients termed high …

Background One of the drugs which is commonly used in diabetic patients is Dipeptidyl
Peptidase-4 (DPP-4) inhibitor. Currently, the association between DPP-4 inhibitor and …